Home LiteratureArticle Details
PMID: 10215638 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Combination of hypoxia/aglycemia compromises in vitro blood-brain barrier integrity.

The Journal of pharmacology and experimental therapeutics ·Vol. 289 ·No. 2 ·1999-05-00 ·Pages 668-75

Abbruscato TJ, Davis TP

Abstract

Increased cerebrovascular permeability is an important factor in the development of cerebral edema after stroke, implicating the blood-brain barrier (BBB) in the pathology of stroke. Present investigations modeled stroke at the level of the cerebral capillary endothelium by analyzing BBB permeability changes to the membrane-impermeant marker [14C]sucrose after hypoxia/aglycemia. Under hypoxia alone, long exposures (48 h) were necessary to result in a significant increase in permeability of bovine brain microvessel endothelial cells to [14C]sucrose. Hypoxia/aglycemia exposures resulted in a much shorter time (i.e., 1-3 h) required for a corresponding increase in permeability to [14C]sucrose. Statistically significant changes in basal permeability were observed between 3 and 6 h of hypoxia/aglycemia; however, 6 h of aglycemia alone had no significant effect on BBB permeability. Both rat astroglioma (C6) cells and C6 conditioned medium showed no improvements in barrier function measured by transendothelial cell resistance or permeability to [14C]sucrose. Changes in endothelial cell calcium flux may be responsible for the permeability change observed after both 48 h of hypoxia and 6 h of hypoxia/aglycemia because nifedipine (10 and 100 nM) and SKF 96365 (100 nM) decreased the permeability change. Immunocytochemical studies also revealed a change in the distribution of endothelial cell F-actin. This study provides evidence that the BBB is sensitive to short exposures of hypoxia/aglycemia and that changes in endothelial cell calcium flux may be responsible for structural and functional variations in the BBB during ischemic stress.

MeSH Terms
Actins/metabolism Animals Blood-Brain Barrier Calcium Channel Blockers/pharmacology Capillary Permeability Cattle Cell Hypoxia Cerebral Cortex/blood supply Coculture Techniques Culture Media, Conditioned Endothelium, Vascular/cytology,physiology Enkephalin, D-Penicillamine (2,5)- Enkephalins/metabolism Glucose/deficiency Imidazoles/pharmacology Insulin/metabolism Nifedipine/pharmacology Receptors, Opioid, delta/agonists Sucrose/metabolism
Chemicals
Actins Calcium Channel Blockers Culture Media, Conditioned Enkephalins Imidazoles Insulin Receptors, Opioid, delta Sucrose Enkephalin, D-Penicillamine (2,5)- 1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole Nifedipine Glucose
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Abbruscato T J
Department of Pharmacology, University of Arizona College of Medicine, Tucson, Arizona, USA.
Davis T P
Article Info
Journal
The Journal of pharmacology and experimental therapeutics
Abbr.
J Pharmacol Exp Ther
ISSN
0022-3565
Published
1999-05-00
Pages
668-75
Language
English
Region
United States
NLM ID
0376362
Subset
IM
Grants
NINDS NIH HHS · NS10580 · United States
NIDA NIH HHS · R01-DA11271 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com